Proteomics Publications
-
- S. Gadwal, TL. Johnson, HA. Remmer, M. Sandkvist. C-terminal processing of Gly-Gly CTERM containing peptides by rhombosortase in vobrio cholerae. PLOS Pathogens, accepted for publication.
- RA. Ohara, HA. Remmer, PL. Campbell, DA. Fox , JH. Ruth. Citrullination of Inhibitor of DNA Binding-1 at Specific Locations Leads to Autoantigenicity in Rheumatoid Arthritis. 2016. Accepted for oral presentation at the ACR/ARHP (American Society for Rheumatology) conference, November 2016, Washington, DC.
- P. Georgoff, I. Halaweish, V. Nikolian, T. Bonham, H. Remmer, R. Menon, B. Liu, Y. Li, HB. Alam. Alterations in the human proteome following administration of valproic acid. 2016. J. Trauma and Acute Care Surgery, accepted for publication.
- WR. Swindell, HA. Remmer, MK. Sarker, X. Xing, DH. Barnes, L. Wolterink, JJ. Vorhees, RP. Nair, A. Johnston, JT. Elder, JE. Gudjonsson. Proteogenomic analysis of psoriasis reveals discordant and concordant changes in mRNA and protein abundance.2015. Genome Med. Aug 4;7 (1):86. Doi: 10.1186/s13073-015-0208-5.e Collection 2015.
- LL. Kubik, RW. Landis, HA Remmer, IL. Bergin, MA. Philbert. 2015. 1,3-dinitrobenzene induces age-and region-specific oxidation to mitochondria –related proteins in brain. Toxicol. Sci. May; 145(1): 48:58. Doi:10.1093/toxsci/kfv015.PMID: 25716674
- MP. Mendez, SB. Morris, S. Wicoxen, M. Du, YK. Monroy, H. Remmer, H. Murphy, PJ. Christensen. R. Paine III. 2008. Disparate Mechanisms of sICAM-1 production in the peripheral lung: contrast between alveolar epithelial cells and pulmonary microvascular endothelial cells. Am. J. Lung Cell Mol. Physiol. 294, L807-L814. doi: 10.1152/ ajplung. 00389.2007
- I.J. Goldstein, H.C. Winter, L. Confer, J.T. Adamson, K. Hakansson, H.A. Remmer 2007.A new a-galactosyl-binding protein from mushroom Lyophyllum decastes. Arch. Biochem. Biophys. 467, 268-274. doi: 10.1016/j.abb.2007.08.017.
- Z.Zhang, H.A. Remmer, D.D.Thomas and C.B. Karim. 2006. Backbone Dynamics Determined by Electron Paramagnetic Resonance to Optimize Solid Phase Peptide Synthesis of TOAC-labeled Phospholamban. Biopolymers Peptide Science, 88 (1) p.29-35. doi: 10.1002/bip.20618.
- H.A. Remmer, N.P. Ambulos, L.F. Bonewald, J.D. Dougherty, E. Eisenstein, E. Fowler, J. Johnson, A. Khatri, M.O. Lively, N.M. Ritter, and S. Weintraub.2004. Synthetic Peptides as Certified Analytical Standards, in Peptide Revolution: Genomics, Proteomics and Therapeutics (M Chorev and TK. Sawyer, eds), Kluwer Academic Publishers, p. 65-66.
- M.M.Rosenblatt, D.L. Huffman, X. Wang, H.A.Remmer & K.S. Suslick. 2002. Cyclic and Hairpin Peptide Complexes of Heme. J. Am. Chem. Soc. 124, 12394-12395.
- K. F.Medzihradszky, N. P. Ambulos, A. Khatri, G. Osapay, H.A. Remmer, A. Somogyi, and S. A. Kates.2002. Mass spectrometry analysis for the determination of side reactions for cyclic peptides prepared from an Fmoc/tBu/Dmab Protecting Group Strategy. Lett. Peptide Sci 8,1-12.
- Khatri, N.P. Amboulos, S.A. Kates, K.F. Medzihradszky, G. Ösapay, H.A. Remmer and A. Sompgyi Strategies for the synthesis of cyclic peptides. 2001. Peptides: The wave of the future (M Lebl and RA Houghton,eds) Kluwer Academic Publishers, p 140-141.
- H.A. Remmer_The Peptide Standards Project Committee. 2001. J. Biomoecular Techniques 12, 3,72-73.
- H.A. Remmer_and G.B. Fields. 1999. Problems encountered with the synthesis of a glycosylated hydroxylysine derivative suitable for Fmoc-solid phase peptide synthesis. In: Peptides: Frontiers of Peptide Science (J.PTam and P.T.P. Kaumaya, eds), Kluwer Academic Publishers, 287-288.
- H.A. Remmer, E. Jaeger, G.Jung, P. Ruecknagel, T. Abdel-Razek and S.I. Said “Structure Activity Studies on VIP III: Synthesis and properties of [Ser(SO3H)3, Ahx17]VIP, [Ahx17]PACAP-27 and the VIP-PACAP-Hybrid [Ahx17, Ala24, Ala25, Val26]VIP-(1-27)-amide” in: Peptides 1994, Proceedings of the twenty-third European Peptide Symposium (HLS Maia, ed) p. 367-368; Escom 1995
- H.A. Remmer, E. Jaeger, P. Ruecknagel & G. Jung. 1994. Comparison of Fmoc-solid phase methods for the synthesis of pure [Nle17] VIP. In: Innovation and Perspectives in Solid Phase Synthesis: Peptides, Proteins and Nucleic Acids Biomedical Applications (R. Epton, ed.) Mayflower Worldwide, Birmingham (1994) p. 657-660.
- E. Jaeger, H.A. Remmer, G. Jung, J. Metzger, W. Oberthuer, K.P. Ruecknagel, W. Schaefer, J. Sonnenbichler & I. Zetl. 1993. Side reactions in peptide synthesis V: “O-Sulfonation of Serine and Threonine during removal of the Pmc- and Mtr-protecting groups from arginine residues in Fmoc solid phase synthesis” Biol. Chem. Hoppe-Seyler, 374 ,349-362.
- E. Jaeger, P. Ruecknagel, H.A.Remmer & G. Jung. 1993. Synthesis and properties of peptides containing O-sulfonated serine and threonine residues.1993. in Chemistry of Peptides and Proteins Vol. 5/6 (D. Brandenburg, V. Ivanov & W. Voelter, eds.), DWI Reports, Vol. 112A, Verlag Mainz, Aachen, 115-124.
- E. Jaeger, G. Jung, H.A. Remmer & P. Ruecknagel“ Formation of amino acid O-sulfonates during removal of the Pmc-group from Arginine residues in SPPS” in: Peptides, Chemistry and Biology, Proceedings of the twelfth American Peptide Symposium (J.A. Smith & J. Rivier, eds.), p. 629-630, Escom Scientific Publishers (1992).
- E. Jaeger, N. Veretennikova, H.A. Remmer & P. Ruecknagel “Synthetic studies on Tuftsin, VIP and gastrin analogs using Fmoc-amino acid-N-carboxyanhydrides in SPPS” in: Peptides 1992 Proceedings of the twenty-second European Peptide Symposium (C.H. Schneider & A.N. Eberle, eds.) p. 226-228; Escom Science Publishers, 1992.
- E. Jaeger, H.A. Remmer, P. Thamm, S.I. Said & H. Sharaf . 1992. Structure activity studies on Vasoactive intestinal peptide: synthesis of analogs modified at residues Asp3-Ala4 and Asn9. Regulatory Peptides 40, 175.
- H.A. Remmer, G. Jung, P. Ruecknagel & E. Jaeger “Facile formation of 2,3-didehydroalanine and 2,3-didehydrobutyrine in peptides containing O-sulfonated serine and threonine residues” in: Peptides 1992, Proceedings of the twenty-second European Peptide Symposium (C.H. Schneider & A.N. Eberle, eds.) p. 167-168; Escom Science Publishers,1992.
Book Chapter
-
- H.A. Remmer and G.B. Fields 2000. Chemical synthesis of peptides. In: Peptides and Protein Drug Analysis (Ronald E. Reid, ed), p. 133-169, Marcel Dekker Inc, New York.
(selected publications without authorship)
- S.M. Rizvi, L. Mancino, V. Thammavongsa, R.L. Cantley, M. Raghavan. 2004. A polypeptide binding conformation of calreticulin is induced by heat shock, calcium depletion, or by deletion of the C-terminal acidic region. Molecular Cell, 15 (6), pp. 913-923. doi: 10.1016/j.molcel.2004.09.001
- J.-F. Couture, E. Collazo, J.S. Brunzelle, RC Trievel. 2005. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase. Genes Dev. June 15; 19(12): 1455–1465. PMCID: PMC1151662. doi: 10.1101/gad.1318405.
- V. Thammavongsa, L. Mancino, M. Raghavan. 2005. Polypeptide Substrate Recognition by Calnexin Requires Specific Conformations of the Calnexin Protein. J. Biol. Chem. 280, 33497–33505 PMID: 16061483. doi:10.1074/jbc.M503648200.
- J.H. Kurzer, P. Saharinen, O. Silvennoinen, C. Carter-Su. 2006. Binding of SH2-B family members within a potential negative regulatory region maintains JAK2 in an active state. Mol Cell Biol 26: 6381–6394, 2006. PMCID: PMC1592834. doi: 10.1128/MCB.00570-06.
- S. Ling, A. Lai, O. Borschukova, P. Pumpens, J. Holoshitz. 2006. Activation of nitric oxide signaling by the rheumatoid arthritis shared epitope. Arthritis Rheum. Nov; 54 (11): 3423-32.
- V. Thammavongsa, G. Raghuraman, T. M. Filzen, K. L. Collins, M. Raghavan. 2006. HLA-B44 polymorphisms at position 116 of the heavy chain influence TAP complex binding via an effect on peptide occupancy. J. Immunol.177, 3150–3161. PMID: 16920953.
- S. M. Rizvi, M. Raghavan. 2006. Direct peptide-regulatable interactions between MHC class I molecules and tapasin. Proc. Natl. Acad. Sci. USA 103: 18220–18225. PMID: 17116884. doi: 10.1073/pnas.0605131103.
- S.Ling, X. Pi, J. Holoshitz. 2007. The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin. J Immunol.179:6359–6367. [PubMed: 17947714]
- S. Ling, Z. Li, O. Borschukova L. Xiao, P. Pumpens and J. Holoshitz. 2007. The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing anadenosine-mediated anti-oxidative pathway. Arthritis Research & Therapy , 9:R5 (doi:10.1186/ar2111)
- Holoshitz J, Ling S. 2007. Nitric oxide signaling triggered by the rheumatoid arthritis shared epitope: a new paradigm for MHC disease association? Ann N Y Acad Sci. 1110:73–83. [PubMed: 17911422]
- R. Nichols. 2007. The first nonsulfated sulfakinin activity reported suggests nsDSK acts in gut biology. Peptides;28:767–73. PMID: 17292511. doi: 10.1016/j.peptides.2007.01.009.
- G.C. Palmer, T. Tran, A. Duttlinger, R. Nichols. 2007. The drosulfakinin 0 (DSK 0) peptide encoded in the conserved Dsk gene affects adult Drosophila melanogaster crop contractions. J Insect Physiol. 53:1125–1133. PMID: 17632121. doi: 10.1016/j.jinsphys.2007.06.001.
- Huang C, Yoshino-Koh K, Tesmer JJG. 2009. A surface of the kinase domain critical for the allosteric activation of G protein-coupled receptor kinases. J. Biol. Chem. 2009, 284:17206-15. doi: 10.1074/jbc.M809544200 PMID: 19364770.
- P. Yang, Y. Mao, A.W.-M. Lee, R.T. Kennedy. 2009. Measurement of Dissociation Rate of Biomolecular Complexes Using Capillary Electrophoresis. Electrophoresis, February; 30(3): 457–464. doi: 10.1002/elps.200800397; PMID: 19148904
- V. Thammavongsa, M. Schaefer, T. Filzen, K.L. Collins, M. Carrington, N. Bangia, M. Raghavan. 2009. Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503. Immunogenetics 61:703–716. PMID: 19838694. doi: 10.1007/s00251-009-0399-2.
- S.J. Segvich, H.C. Smith, D.H. Kohn. 2009. The adsorption of preferential binding peptides to apatite-based materials. Biomaterials, 30 (7), pp. 1287–1298. PMID: 19095299. doi: 10.1016/j.biomaterials.2008.11.008
- SA Robertson, RI Koleva, LS Argetsinger, C Carter-Su, JA Marto, EP Feener, MG Meyers Jr. 2009.Regulatoin of Jak2 function by phosphorylation of Tyr317 and Tyr637 during cytokine signaling. Mol. Cell Biol. Jun; 29(12);3367-3378. PMID:19364823 PMCID: PMC2698725; doi: 10.1128/MCB.00278-09
- H. Yao, D.M. Veine, Z.Z. Zeng, K.S. Fay, E.D. Staszewski, D.L. Livant. 2010. Increased potency of the PHSCN dendrimer as an inhibitor of human prostate cancer cell invasion, extravasation, and lung colony formation. Clin. Exp. Metastasis 27:173–184. PMID: 20339907. doi: 10.1007/s10585-010-9316-1.
- C.G. Besirli, N.D. Chinskey, Q.-D. Zheng, D.N. Zacks. Inhibition of retinal detachment–induced apoptosis in photoreceptors by a small peptide inhibitor of the Fas receptor. Invest Ophthalmol. Vis Sci. 2010;51(4):2177–2184. PMCID: PMC2868404. doi: 10.1167/iovs.09-4439.
- P. Kamarajan, A. Garcia-Pardo, N.D’Silva, Y Kapila. 2010. The CS1 segment of fibronectin isinvolved in human OSCC pathogenesis by mediating OSCC cell spreading, migration, and invasion BMC Cancer 2010, 10:330; doi: 10.1186/1471-2407-10-330; PMID: 20579373.
- S. Ling, A. Cheng, P. Pumpens, M. Michalak, J. Holoshitz. 2010. Identification of the Rheumatoid Arthritis Shared Epitope Binding Site on Calreticulin. PLoS ONE 5(7): e11703. doi:10.1371/journal.pone.0011703
- D. E. De Almeida, S. Ling, X. Pi*, A. M. Hartmann-Scruggs, P. Pumpens, and J.Holoshitz. 2010. Immune Dysregulation by the rheumatoid shared epitope. J Immunol. August 1; 185(3): 1927–1934. doi:10.4049/jimmunol.0904002; PMID: 20592276
- P.A. DelRizzo, J.-F. Couture, L.M.A. Dirk, B.S. Strunk, M.S. Roiko, J.S. Brunzelle, R.L. Houtz, R.C. Trievel. 2010. SET7/9 Catalytic Mutants Reveal the Role of Active Site Water Molecules in Lysine Multiple Methylation J. Biol. Chem. 285 (41):31849-31858. PMCID: PMC2951256. doi: 10.1074/jbc.M110.114587
- LS Argetsinger, JA Stuckey, SR Robertson, RI Koleva, JM Cline, JA Marto, MG Myers Jr, C. Carter-Su. 2010. Tyrosines 868, 966 and 972 in the kinase domain of Jak2 are autophosphorylated and required for maximal Jak2 kinase activity. Mol. Endocrinol. 2010 Mar 19 PMID: 20304997.
- H. Yao, D.M. Veine, K. Fay, E. Staszewski, Z.Z. Zeng, D. Livant. 2011. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation. Breast Cancer Res Treat. ;125:363–375. PMID: 20300829. doi: 10.1007/s10585-010-9316-1.
- N. Gupta and S.W. Ragsdale. 2011. Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor Rev-erb. J. Biological Chem. 286 (6): 4392-4403. Doi: 10.1074/jbc.M110.193466; PMID: 21123168.